Novartis AG Impairment Loss Recognised In Profit Or Loss Intangible Assets And Goodwill
Novartis AG (NVS) reported Impairment Loss Recognised In Profit Or Loss Intangible Assets And Goodwill of $557.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsAndGoodwill · last filed 2026-02-04
| Period end | Impairment Loss Recognised In Profit Or Loss Intangible Assets And Goodwill 12 month |
|---|---|
| 2025-12-31 | $557.00M 20-F · filed 2026-02-04 |
| 2024-12-31 | $1.43B 20-F · filed 2026-02-04 |